Perhaps one of the most significant recent achievements in medical science has been the development of induced Background-The use of cells derived from human induced pluripotent stem cells as cellular therapy for myocardial injury has yet to be examined in a large-animal model. Methods and Results-Immunosuppressed Yorkshire pigs were assigned to 1 of 3 groups: A myocardial infarction group (MI group; distal left anterior descending coronary artery ligation and reperfusion; n=13); a cell-treatment group (MI with 4×10 6 vascular cells derived from human induced pluripotent stem cells administered via a fibrin patch; n=14); and a normal group (n=15). At 4 weeks, left ventricular structural and functional abnormalities were less pronounced in hearts in the cell-treated group than in MI hearts (P<0.05), and these improvements were accompanied by declines in scar size (10.4±1.6% versus 8.3±1.1%, MI versus cell-treatment group, P<0.05). The cell-treated group displayed a significant increase in vascular density and blood flow (0.83±0.11 and 1.05±0.13 mL·min
H eart failure is the end-stage clinical syndrome for a variety of cardiovascular diseases and affects more than 23 million patients worldwide, including 5.8 million in the United States. 1, 2 The healthcare expenses associated with heart failure cost the US government more than $39 billion annually. 1, 2 Heart failure often develops after acute myocardial infarction (MI) because the injured myocardial tissue fails to recover or regenerate. 3 The heart has long been considered a postmitotic organ and incapable of self-renewal; however, recent reports have demonstrated that progenitor cells mediate cardiomyocyte turnover in normal adult hearts 4 and that heart tissue can regenerate after injury through the differentiation of cardiac progenitor cells (CPCs) and through activation of the cell cycle in cardiomyocytes. 5 The endogenous rate of cardiomyocyte regeneration is too slow to replace the cardiomyocytes that are lost during ischemia, but these mechanisms of cardiomyocyte turnover may be a key component of the therapeutic effects associated with cellular therapies, [6] [7] [8] which have recently been shown to benefit patients with postinfarction left ventricular (LV) remodeling.
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pluripotent stem cells (iPSCs). 11, 12 These cells reproduce much of the regenerative potential possessed by pluripotent embryonic stem cells but are generated from a patient's own somatic cells and consequently minimize the ethical concerns and potential immunogenic complications associated with embryonic stem cell therapies. The myocytes generated through cellular therapy, or from the activity of endogenous progenitor cells, are believed to reduce LV dilatation and bulging at the site of infarction, which subsequently decreases myocardial wall stress and improves myocardial function and metabolism 7, 13, 14 ; however, the use of iPSCs or cells derived from iPSCs for the treatment of ischemic myocardial injury has not yet been examined in a clinically relevant large-animal model.
The hypothesis that cardiac dysfunction in failing hearts develops because of energy starvation is an old one 15 ; however, whether the decreased reserve of myocardial ATP turnover rate contributes to the progression of cardiac dysfunction is largely a topic for speculation, because accurate measurements of myocardial ATP turnover rates cannot be made in vivo. Although the magnetic resonance spectroscopy-magnetization saturation transfer (MRS-MST) technique has been used extensively to measure ATP flux via creatine kinase, the accurate evaluation of ATP turnover rates via mitochondrial and cytosolic enzymes (ADP+P i ↔ATP) has generally not been successful in vivo because the level of myocardial free inorganic phosphate (P i ) is too low to be measured directly. 16, 17 Here, we introduce a novel MRS-MST method that enables us to calculate the ATP hydrolysis rate without measuring P i levels (see online-only Data Supplement for mathematical demonstration), which overcomes the primary barrier in determining the ATP turnover rate in vivo. The accuracy of this method was examined rigorously and confirmed in both skeletal muscle and the heart under baseline and high cardiac workloads. Using an immunosuppressed swine model of postinfarction LV remodeling and this novel nuclear magnetic resonance technique, we examined the hypothesis that in vivo hearts with postinfarction LV remodeling have a decreased reserve of myocardial ATP turnover rate. We hypothesized that treatment with an epicardial fibrin patch-enhanced delivery of vascular cells derived from human iPSCs (hiPSC-VCs) would decrease the periscar border zone (BZ) myocardium overstretch and wall stresses, which in turn would result in an improvement in myocardial ATP turnover rate.
Methods
A more detailed description of the experimental procedures used in this investigation is provided in the online-only Data Supplement.
Generation of Vascular Cells From Human iPSCs
The characteristics of the human iPSCs (hiPSCs) used for these studies were provided in Knorr et al. 18 The generation of iPSCs from neonatal human dermal fibroblasts was accomplished by lentiviral transduction of OCT4, SOX2, KLF4, and cMYC. 19 The iPSC criteria include polymerase chain reaction and immunostaining of pluripotent markers including Oct3/4, Sox2, Nanog, SSEA-4, and Tra-1-81; ability to form teratomas; and normal karyotype. hiPSCs that expressed green fluorescent protein (GFP) were generated separately by the "Sleeping Beauty" transduction method (Amaxa, Gaithersburg, MD), as described previously. 20 The GFP + hiPSCs were then subjected to vascular differentiation by a previously published protocol for human embryonic stem cells. 21 The hiPSC-VCs consisted of 2 distinct cell types that corresponded to endothelial cells and smooth muscle cells (SMCs).
Swine Model of Ischemia Reperfusion and Cell Transplantation
The experimental protocol was approved by the University of Minnesota Research Animal Resources Committee. All experimental and animal maintenance procedures were performed in accordance with the animal use guidelines of the University of Minnesota and were consistent with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals (NIH publication No. 85-23).
Female Yorkshire farm swine (weight ≈15 kg; Manthei Hog Farm, Elk River, MN) were randomly assigned to 1 of 3 experimental groups: A cell-treatment group (MI with 4×10 6 hiPSC-VCs administered via a fibrin patch; n=14); an MI group (distal left anterior descending coronary artery ligation and reperfusion; n=13); and a normal group (n=15). Ischemia-reperfusion injury was surgically induced in animals from the cell-treatment and MI groups by temporary ligation of the coronary artery for 60 minutes as described previously 13, 22 and as summarized in the online-only Data Supplement; animals in the normal group underwent the same surgical procedure except for the ligation step. A fibrin patch that contained 4 million hiPSC-VCs (hiPSC endothelial cells and hiPSC SMCs, 2 million each) was placed over the ligation site of hearts in the cell-treatment group. 22 Because the transplanted cells were of human origin, the immune systems of animals in all 3 experimental groups were suppressed via cyclosporine injection (15 mg·kg −1 ·day −1 , supplemented with food). 
Contractile Function and Infarct Size
Cardiac functional parameters (LV ejection fraction and systolic thickening fraction) and infarct size were evaluated via magnetic resonance imaging as summarized in the online-only Data Supplement. Measurements were performed with a 1.5-T clinical scanner (Siemens Sonata, Siemens Medical Systems, Iselin, NJ); functional parameters were determined from short-axis cine images, and infarct sizes were determined via delayed-enhancement magnetic resonance imaging.
Myocardial ATP Turnover Rate
In vivo measurements of the myocardial ATP turnover rate were obtained via an open-chest 31 P MRS-MST protocol as summarized in the online-only Data Supplement. Measurements were performed on a 65-cm-bore 9.4-T magnet interfaced with a VnmrJ console (Varian, CA). Radiofrequency transmission and MRS signal detection were performed with a double-tuned ( 1 H and 31 P) surface coil (28-mm diameter). BZ measurements were obtained by suturing the coil directly to the LV epicardium over the peri-infarct region in hearts from the MI and cell-treatment groups, and remote zone measurements were obtained by suturing the coil over a noninfarcted region; measurements in normal hearts were obtained with the coil positioned on the anterior wall. Measurements were performed both under baseline conditions and a high cardiac work state induced by catecholamine stimulation (dobutamine and dopamine, each 10 μg·kg −1 ·min −1 IV). A complete theoretical derivation of our experimental approach is provided in the online-only Data Supplement. Briefly, the in vivo metabolism of ATP can be modeled as a chemical exchange network comprising 2 reactions among 3 components: The shuttling of inorganic phosphate (P i ) between phosphocreatine (PCr) and ATP (PCr↔ATP) and the hydrolysis/condensation of ATP (ATP↔ADP+ P i ). The kinetics of ATP metabolism can be summarized with 2 pseudo first-order rate constants: K PCr→ATP for the forward creatine kinase reaction and K ATP→Pi for ATP→ P i hydrolysis reactions. The K ATP→Pi includes contributions from (1) all of the contraction/ relaxation-associated reactions that are energized by ATP and (2) additional substantial contributions from a cytosolic near-equilibrium enzyme complex composed of GAPDH and phosphoglycerate kinase. Because the PCr↔ATP reaction is at equilibrium, the rate of the 
where K ATP→Pi is the pseudo first-order rate constant of the ATP→ADP+P i reaction; M 0 and T 1 int are the fully relaxed magnetization and intrinsic longitudinal relaxation time constants of spin, respectively, as determined via 31 P MRS; M ss,ATPγ is the steady-state magnetization of ATPγ when PCr and P i are completely saturated; and M ss,PCr is the steady-state magnetization of PCr when ATPγ is completely saturated. The measurement of K ATP→Pi can be achieved from as few as 3 spectra, 1 taken with the ATPγ signal saturated to measure the steady-state magnetization of PCr (M ss,PCr ), 1 taken with both P i and PCr saturated to measure the steady-state magnetization of ATPγ (M ss,ATPγ ), and 1 taken with no saturation to measure the magnetization of PCr and ATPγ (M 0,PCr and M 0,ATPγ ). The validity of the methodology was rigorously examined on swine skeletal muscle (n=5), where P i is reliably measureable; the results from the novel approach were compared with those from the conventional MST method. Details of validation experiments are provided in the online-only Data Supplement.
Myocardial Perfusion, LV Hemodynamics, and Histological Assessments
Evaluations were performed after the chest had been opened for the 31 P MRS assessments. Myocardial perfusion was measured via the injection of fluorescently labeled microspheres as described previously. [23] [24] [25] LV hemodynamics were monitored via a catheter inserted through the apical dimple and into the LV, 23 and histological assessments were performed according to standard protocols. More detailed descriptions of these experimental procedures are provided in the online-only Data Supplement.
Statistical Analysis
All data are reported as mean±SD. Statistical analyses were performed with SigmaStat version 3.5 (San Jose, CA). Comparisons among groups were analyzed for significance with 1-way ANOVA. Comparisons among different time points and between experimental groups were performed with 2-way repeated-measures ANOVA. P<0.05 was considered significant. When ANOVA demonstrated a significant effect, post hoc analysis was performed with the t test with Bonferroni correction. Comparisons of experimental condition versus baseline within a group were performed with a paired t test. Comparisons between groups were performed with an unpaired t test. Linear regression and correlation analyses were performed to analyze the variables of rate-pressure product, LV systolic thickening fraction, end-diastolic volume, and wall stress versus the myocardial flux rate of the ATP hydrolysis reaction.
Results
hiPSC-Derived Vascular Cells
The hiPSC-VCs consisted of 2 distinct cell types: hiPSCderived endothelial cells and hiPSC-derived SMCs ( Figure 1 ). The hiPSC endothelial cells expressed endothelial markers such as CD31, CD73, CD105, CD144, CD146, and von Willebrand factor and formed robust tubelike structures when cultured in Matrigel ( Figures 1A through 1C) . The hiPSC SMCs displayed a typical SMC phenotype and expressed the SMC markers smooth muscle actin (SMA), SM22, and calponin ( Figure 1D ). These results are consistent with those obtained when human embryonic stem cells were cultured with the same vascular differentiation protocol. One week after MI injury, infarcts were ≈10% of the size of the LV in hearts in both the MI and cell-treatment groups ( Figure 2A ) and were accompanied by evidence of cardiac remodeling, such as cardiac hypertrophy ( Figure 2B ) and dilatation ( Figure 2C) ; however, infarcts at week 4 were significantly smaller and remodeling was significantly less extensive in hearts in the cell-treatment group than in MI hearts. MI injury also led to a significant decline in LV ejection fraction ( Figure 2D ). However, the systolic thickening fraction at the BZ of the infarct ( Figure 2E ) was significantly greater in hearts in the cell-treatment group than in MI hearts, and the bulging of the infarct was also prevented by cell treatment ( Figure 2E ); these improvements were accompanied by declines in measurements of myocardial wall stress at both the BZ and infarct zone ( Figure 2F ). Cardiac hemodynamic parameters in hearts in the MI and cell-treatment groups were similar to measurements in normal hearts both at baseline and during high cardiac work states (Table 1) , which suggests that the injured hearts were in the compensated phase of LV remodeling. Typical cardiac magnetic resonance images of hearts from each of the experimental groups at end diastole and end systole are shown in Figure 2G . Videos of typical hearts from each of the experimental groups are provided in the online-only Data Supplement.
hiPSC-VC Transplantation Improved Myocardial Energetics After MI
Recently, we used a novel 31 P MRS 2-dimensional chemical shift imaging protocol to demonstrate that the effect of MI injury on myocardial bioenergetics is heterogeneous: PCr/ ATP ratios declined near the border of the infarcted region but not (or to a much lesser extent) in remote (ie, noninfarcted) tissue. 7 The results obtained in the present investigation with hiPSC-VCs are consistent with our previous report: The PCr/ ATP ratio was significantly lower at the BZ of the infarct in MI hearts than in normal hearts under baseline workload conditions and was significantly improved by hiPSC-VC treatment ( Table 2 ). For the study reported here, we further developed another 31 P MRS protocol that enabled us to measure, in vivo, the myocardial ATP turnover rate in different regions of the heart.
In the heart, ATP turnover can be modeled as a chemical exchange network with 3 components (PCr↔ATP↔P i ), and the kinetics of ATP metabolism can be summarized with 2 pseudo first-order rate constants (K PCr → ATP for the creatine kinase reaction and K ATP → Pi for the ATP→P i reaction . Myocardial ATP turnover rates were determined in vivo as illustrated in Figure 3 and were rigorously validated Figure 3A ; saturation of ATPγ) and inversion recovery ( Figure 3B ; double saturation of both PCr and P i ), respectively. At 9.4 Tesla, T 1 int in the heart was 1.1±0.1 seconds for ATPγ and 3.2±0.1 seconds for PCr, which is in good agreement with measurements in skeletal muscle (online-only Data Supplement Table I ) and with previously reported values at the same magnetic field. 26 These observations indicate that T 1 int is determined by the microenvironment of the magnetic field that surrounds a given molecule and is not affected by physiological or pathological conditions or by the kinetics of the chemical exchange network.
Kinetic measurements (K PCr → ATP and K ATP → Pi ) were performed via a 3-spectrum MST experiment ( Figure 3C ). In normal hearts, Flux ATP → Pi measurements were linearly related to the rate-pressure product (LV pressure×heart rate; Figure 3D ), which indicates that the ATP→P i turnover rate and cardiac workload are tightly coupled. MI injury was associated with significantly lower K ATP → Pi measurements at the BZ of the infarct under both baseline and high-workload conditions ( Figure 3E ). However, K ATP → Pi measurements in the remote zone were unchanged (K ATP → Pi from remote zone of MI hearts [n=5] was 0.15±0.03 s −1 , P=NS versus normal hearts), which indicates that the effect of infarction on ATP turnover rate is localized to the BZ at this phase of the LV remodeling. Although the rate-pressure product in response to catecholamine stimulation in MI and normal hearts was similar (Table 1) , the K ATP → Pi of BZ from MI hearts was less responsive. The decline in K ATP → Pi measurements observed at the BZ of MI hearts was significantly improved by hiPSC-VC treatment ( Figure 3E ). The BZ Flux PCr → ATP was significantly lower in MI hearts than in normal hearts. K PCr → ATP measurements in hearts in the normal, MI, and cell-treatment groups were similar under both baseline and high-workload conditions ( Figure 3F and 4A).
Myocardial flux of the PCr→ATP and ATP→P i reactions are summarized in Figure 4A . The concentration of ATP in the myocardium of swine hearts (5.3 μmol/g wet weight) has been determined previously. 27, 28 Flux PCr→ATP and Flux ATP→Pi were significantly lower in the BZ of hearts in both the MI and cell-treatment groups than in the corresponding region of normal hearts, and Flux ATP→Pi but not Flux PCr→ATP was improved by hiPSC-VC treatment ( Figure 4A ). Flux ATP→Pi was also linearly correlated with measurements of the myocardial systolic thickening fraction, BZ wall stress, and LV end-diastolic volume ( Figures 4B through 4D ). These findings are consistent with existing understanding that regional wall stress is a key determinant of metabolic activity and demand and contractile element response.
29
Survival and Engraftment of hiPSC-VCs in Infarcted Swine Heart
The transplanted hiPSC-VCs had been engineered to express GFP; thus, the engraftment of hiPSC-VCs into the myocardial vasculature was evaluated by staining for the expression of GFP, CD31, and SMA, and proliferation was evaluated by staining for bromodeoxyuridine (BrdU) incorporation in the hearts of animals that had been infused with BrdU (10 mg·kg
, administered via an insulin pump) for 7 days. GFP + cell counts indicated that the engraftment rate was 7.1±0.8% of the total number of cells transplanted per animal at week 1 and 2.3±0.9% at week 4 ( Figure 5A ). The transplanted hiPSC-VCs appeared to integrate into preexisting vessels ( Figure 5B ) and to generate new vessel growth in the area of the fibrin patch ( Figure 5C ), and abundant evidence of BrdU incorporation by GFP + cells confirmed that the engrafted hiPSC-VCs were highly proliferative (online-only Data Supplement Figure II ). MI injury led to a severe loss of vascularity, as evidenced by the minimal amount of CD31 and SMA expression observed at the BZ of the infarct in hearts from the MI group; however, both CD31 + and SMA + vascular density was significantly greater in cell hearts than in MI hearts (Figures 5D through 5G). To determine whether the increase in vascular density was accompanied by a corresponding increase in blood flow, regional myocardial blood flow was measured via cardiac magnetic resonance imaging and microsphere injection 30, 31 (n=4 per group), and coronary reserve was examined by use of adenosine-induced myocardial hyperemia (0.5 mg·kg
. 23, 32 These data demonstrate that cell treatment led to significant increases in BZ myocardial perfusion ( Figure 5H ), which were accompanied by significant improvements in systolic thickening fractions and ATP turnover rate in this region of the myocardium (Figure 4 ). Myocardial blood flow also tended to be higher in hearts from the cell-treatment group during hyperemia ( Figure 5I ), but the difference between hearts from the cell-treatment and MI groups was not significant ( Figure 5I ), and calculation of the coronary flow reserve did not identify significant differences among experimental groups or between different regions of myocardium ( Figure 5I ). Collectively, these observations demonstrate that the transplanted hiPSC-VCs were able to integrate into the growing vasculature and to generate new vessels, which suggests vasculogenesis. However, fewer than 5% of vessels expressed GFP, so the enhanced vascularity and perfusion associated with cell treatment likely evolved primarily through the sprouting of preexisting vessels.
hiPSC-VC Transplantation Stimulated the Activation and Proliferation of Endogenous CPCs and Cardiomyocytes
To determine whether cell therapy enhanced the activation and proliferation of endogenous CPCs, sections were stained for the presence of α-sarcomeric actin (to identify cardiomyocytes), for expression of the progenitor cell marker c-kit, and for BrdU incorporation ) for phosphocreatine (PCr) and ATPγ using progressive saturation (A) and inversion recovery (B) experiments. Spectra a1 through a7 are from progressive saturation experiment with ATPγ saturated (arrow) for 0.44, 0.88, 1.32, 2.2, 3.52, 5.28, and 7.04 seconds, respectively. Spectra b1 through b6 are from inversion recovery experiment with both inorganic phosphate (P i ) and PCr saturated (arrows) for 0.44, 0.88, 1.32, 1.76, 2.64, and 3.96 seconds, respectively. The magnetizations of PCr and ATPγ were quantified and then subjected to exponential models to fit the intrinsic T 1 s. The experiments yielded an average intrinsic T 1 of 3.2±0.1 seconds and 1.1±0.1 seconds for PCr and ATPγ, respectively. C, Three-spectrum magnetization saturation transfer experiment to measure myocardial ATP turnover rate based on the equation given in Methods. c1 indicates control spectrum without saturation to quantify magnetization of PCr (M 0,PCr ) and ATPγ (M 0,ATPγ ); c2, ATPγ-saturated spectrum to quantify steady-state magnetization of PCr (M ss,PCr ); and c3, P i -and PCr-saturated spectrum to measure steady-state magnetization of ATPγ (M ss,ATPγ ). BISTRO-based frequency-selective saturation pulses are indicated by arrows. Detailed information of BISTRO (B1-insensitive train to obliterate signal) saturation pulse sequence is shown in online-only Data Supplement Figure IV. 2,3-DPG indicates 2,3-diphosphoglycerate. D, Scatterplot of Flux ATP→Pi vs rate-pressure product (RPP) for individual hearts from normal group, which indicates a tight coupling between ATP hydrolysis rate and cardiac workload (R 2 =0.89, P<0.05). E and F, Summarization of myocardial K ATP→Pi and K PCr→ATP for all groups at both baseline and high cardiac workload (HWL) conditions. K ATP→Pi is significantly reduced in border zone of myocardial infarction (MI) hearts compared with normal hearts, whereas K PCr→ATP was similar among all groups and all conditions. In response to transplantation of human induced pluripotent stem cell-derived vascular cells, the abnormality of ATP turnover rate in border zone was abolished. Flux ATP→Pi was calculated from K ATP→Pi ×[ATP].
[ATP] value was estimated to be 5.3 μmol/g wet tissue weight for normal myocardium. #P<0.05 vs normal group; *P<0.05 vs MI group; ‡P<0.05 vs same group in baseline condition. Quantification of myocardial ATP turnover rate was based on normal hearts (n=10), MI hearts (n=8), and hearts treated with cell therapy (n=9). by guest on April 29, 2017 http://circ.ahajournals.org/ Downloaded from cells were common in the injury site of hearts from the MI group, and the proportion of c-kit + cells that were also positive for BrdU incorporation was significantly higher in MI hearts than in normal hearts ( Figures 6C and 6D ). c-kit + cells often coexpressed the cardiac cell marker GATA-4, but cells that coexpressed c-kit and the hematopoietic cell marker CD45 were rare ( Figures 6E and 6F ), which suggests that many of the progenitor cells were committed to the cardiac lineage and that inflammatory cells were not a significant source of c-kit expression. Furthermore, both the number of c-kit + cells and the incorporation rate of BrdU by c-kit + cells were significantly greater in hearts from the cell-treatment group than in MI hearts at week 1 but not at week 4. Thus, the transplanted hiPSC-VCs appeared to enhance the endogenous response to MI by transiently increasing both the number and proliferation of CPCs in the infarcted region. The proportion of cardiomyocytes that were positive for BrdU incorporation was also significantly higher in the BZ of hearts from the cell-treatment group than in the corresponding region of hearts from MI animals ( Figures 7A through E) , and BrdU + cardiomyocytes were significantly smaller than BrdU − cardiomyocytes from the same region ( Figure 7F ), which suggests that the enhanced activation of CPCs was accompanied by increases in cardiomyocyte turnover.
Discussion
One of the most unsettled questions in cardiovascular physiology is how the rate of ATP production and utilization is regulated in the heart and how the limitation of this rate may contribute to contractile dysfunction in hearts that become hypertrophic in response to MI-induced LV remodeling, pressure overload, or volume overload. The heart has the highest ATP turnover rate per gram of tissue of any organ in the body 33 ; however, the ATP reserve in myocardial tissue is so low that it would be exhausted after only a few dozen beats if the ATP production machinery stopped functioning. 33 In vivo methods for accurately measuring the ATP utilization rate in the heart have not been established because multiple mechanisms for ATP turnover happen simultaneously, 34 and the conventional method requires quantification of the intracellular P i level, which is intrinsically low and overlaps with 2,3-diphosphoglycerate resonance peaks. In addition, whether intracellular levels of myocardial free P i are completely visible on nuclear magnetic resonance is somewhat controversial. 16, 17 In the present report, we introduce a novel, double-saturation 31 P MST protocol that measures the ATP utilization rate without measuring P i , thereby circumventing the barrier for in vivo applications (online-only Data Supplement). By applying this nuclear magnetic resonance method, we have observed abnormalities in the rate of ATP utilization at the BZ of infarction; furthermore, the BZ bioenergetic abnormality was significantly corrected in response to cell therapy, and this improvement was associated with significantly increased BZ contractile function (Figures 2 and 4) . The observation that ATP hydrolysis/synthesis rates increased in the BZ of celltreated hearts (Figure 4) is not surprising given the significant volume of literature that suggests that the factors responsible for myocyte overstretch and elevations in wall stress also lead to a decline in contractile function 29 and that correcting these factors would contribute to increases in the BZ systolic thickening fraction. 13 However, in the in vivo heart, the mechanisms responsible for this simple observation likely involve multiple factors throughout the network of ATP machinery, which functions seamlessly to maintain the balance between energy delivery and demand for the contractile apparatus. 34, 35 A more comprehensive and inclusive discussion of these mechanisms is beyond the scope of the present investigation, but future studies combining measurements of in vivo ATP turnover rates and intermediary metabolism 36 with measurements of changes in protein activity, the expression levels of creatine kinase isozymes, 27 and ATPase subunits 28, 37 and isolated mitochondrial function could advance our understandings of the 
Validation of ATP Utilization Rate Measurements in Skeletal Muscle
Methods for accurately measuring the total rates of myocardial ATP synthesis (or utilization) in the in vivo heart have not been established because of difficulties in accurate measurement of myocardial free P i level. 38 In the present report, we have introduced and rigorously validated a novel 31 P MST protocol that measures the ATP utilization rate without the need for a P i measurement. The validation experiments were performed in swine skeletal muscle, in which adequate P i resonance definition ensured that measurements could be made with both the new and the classic MST techniques (onlineonly Data Supplement Figure I ). The equivalence of the results obtained with the novel and classic methods validates our new method for measuring the K ATP→Pi and Flux ATP→Pi in the in vivo heart, in which the myocardial free P i level is too low to be quantified accurately. . C-F, Representative vascular staining from (C) a cell-treatment heart at patch/myocardium border, (D) a normal heart, (E) a heart in the myocardial infarction (MI) group at border zone (MI-BZ), and (F) a cell-treatment heart at border zone (CELL-BZ). Vessels were visualized by CD31 staining (green) and SMA staining (red), whereas myocardium was visualized by cardiac troponin I (cTnI) staining (blue). G, Summarization of quantification of arteriolar density (SMA + vessels with diameter >25 μm) and total vascular density (all CD31 + vessels). H and I, Summarization of microsphere-based myocardial blood flow (MBF) data examined at 4 weeks after infarction. MBF measurements were performed at both baseline (H) and during hyperemia (I; adenosine 0.5 mg·kg 
Myocardial ATP Turnover Rate in the In Vivo Heart
In response to acute MI, molecular, structural, and functional abnormalities first occur in the BZ. The surviving BZ myocytes are overstretched and then spread to adjacent regions of healthy myocardium until the entire LV is affected and signs of heart failure appear. 28, 39 The present findings demonstrate that the Flux ATP→Pi rate in MI hearts is highly heterogeneous, with a pronounced reduction in the BZ but not in the remote zone. Although the underlying mechanisms responsible for the decline in BZ Flux ATP→Pi and its failure to increase in response to catecholamine stimulation are beyond the scope of the present investigation, these mechanisms are likely similar to those present in myocardium of failing hearts, which show downregulation to catecholamine stimulation.
The decline in BZ Flux ATP→Pi was accompanied by contractile dysfunction, a loss of vascular density, and elevated wall stress. Previous reports using both a localized 31 P MRS protocol and, more recently, a 2-dimensional chemical shift imaging technique 7, 28 have shown that the PCr/ATP ratio and, by extension, the bioenergetic efficiency of the BZ are impaired. This abnormal bioenergetic status is related to elevations in BZ wall stress, which could contribute to the progression of the disease state from compensated MI to congestive heart failure. The decline in BZ Flux ATP→Pi is also consistent with previous observations that the number of F 1 F 0 -ATPase subunits is severely reduced in the BZs of compensated swine hearts with LV remodeling. 28, 37 The present observation that the ATP hydrolysis rate is severely reduced in BZ myocardium that was recovered in response to the patch-enhanced cell treatment suggests that cellular therapy targeting the BZ of hearts in the compensated phase of remodeling may prevent progression to heart failure ( Figures 4C and 4D) .
The transplantation of hiPSC-VCs corrected the regional abnormalities in ATP hydrolysis rate that were observed in MI hearts (Figure 4 ). This beneficial effect on ATP hydrolysis supports the previous observation that cell transplantation into infarcted hearts improved myocardial bioenergetics, as indicated by the PCr/ATP ratio, 7, 13, 14 and that these bioenergetic benefits were accompanied by significant improvements in BZ myocardial contractile function, wall stress, vascular density, and myocardial blood flow. Future investigations are warranted to identify the molecular pathways that are induced by myocyte overstretching and support the beneficial effects of cardiac cell therapy.
The hypothesis that failing hearts are energy starved is an old one. 15 On the basis of studies that used animal models of heart failure and patients with LV hypertrophy, it is a rather consistent finding that myocardial HEP levels and the forward flux rate of creatine kinase are reduced significantly, which is linearly related to the severity of LV dysfunction. 23, 27 Myocardial HEP levels 23, 32 and creatine kinase kinetics have been studied extensively 27 ; however, rates of ATP hydrolysis have been largely overlooked in in vivo investigations because of the intrinsically low myocardial P i level. In the in vivo heart, myocardial P i produces a weak signal that overlaps with the resonance peaks of 2,3-diphosphoglycerate from erythrocytes in LV chamber blood. Our novel double-saturation 31 P MRS protocol enables the ATP hydrolysis rate to be calculated without quantification of the P i signal, thereby providing a new approach for the study of myocardial ATP turnover rate in vivo (online-only Data Supplement). The ATP hydrolysis rate is important because it reflects the total ATP utilization rate, combining the contractile apparatus utilization and all other ATPase pumps that maintain the structural integrity.
Transplanted hiPSC-VCs Enhanced Activation and Proliferation of Endogenous CPCs for Cardiac Repair
The paradigm of the heart as a postmitotic organ incapable of regeneration has been challenged by the discovery that cardiomyocytes can reenter the cell cycle and begin dividing and by the presence of CPCs in the adult heart that are capable of generating new cardiomyocytes. 4, 5, 7, 8, 40, 41 Here, we show that MI led to the activation of c-kit + cells at the injury site, which is consistent with previous reports. 8 , 42 The higher c-kit + cell density in cell hearts was accompanied by a significantly ). An average of >10 000 cardiomyocytes were analyzed per group. *P<0.05 vs RZ from same time point within same group; # P<0.05 vs MI group from same region and same time point; ‡P<0.05 vs same group at week 1. F, Quantification of myocyte size (cross-sectional diameter) from BZ myocardium of cell-treatment heart at week 4. BrdU + myocytes were significantly smaller than BrdU − myocytes. CM indicates cardiomyocytes. by guest on April 29, 2017 http://circ.ahajournals.org/ Downloaded from higher rate of BrdU incorporation ( Figure 6C ), which suggests that hiPSC-VC transplantation also increased c-kit + cell proliferation. The present data also show that hiPSC-VC transplantation increased the BrdU incorporation rate of BZ cardiomyocytes at week 4 after injury. Collectively, these observations suggest that hiPSC-VC transplantation activates endogenous progenitor cells, which may contribute to the increased myocyte turnover.
In conclusion, the present study introduces a novel MRS-MST approach for obtaining in vivo measurements of the myocardial ATP hydrolysis rate. The ATP hydrolysis rate was linearly related to the rate-pressure product but was significantly reduced in the BZ of infarction, perhaps because of increases in wall stress in this region. Transplantation of hiPSC-VCs significantly increased the activation of endogenous CPCs in response to MI injury, which was accompanied by significant improvements in myocardial wall stress, vascular density, infarct size, and contractile function, as well as the ATP utilization rate. These beneficial effects may impede progression from the compensated phase of myocardial hypertrophy to heart failure.
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SUPPLEMENTAL MATERIALS SUPPLEMENTAL THEORY
Conventional magnetization saturation transfer (MST) experiment
The in vivo metabolism of adenosine triphosphate (ATP) can be modeled as a chemical exchange network among phosphocreatine (PCr), ATP, and inorganic phosphate (Pi):
where the PCr↔ATP exchange is catalyzed by creatine kinase (CK), the ATP↔Pi exchange incorporates all other cellular activities that produce and consume ATP, 
Indirect
P MRS-MST method for measuring ATP turnover rates in vivo
The conventional MST approach for measuring the ATP↔Pi rate constant in vivo relies on the quantification of Pi magnetization levels (M Pi ), 11 which is difficult in vivo because myocardial Pi levels are intrinsically low, and because of overlap between the peaks for Pi and 2,3-diphosphoglycerate (2,3-DPG), which is generated from erythrocytes in the blood. Furthermore, there is some controversy about whether intracellular cardiac Pi is completely visible in an MR spectrum. 12, 13 Here, we introduce a novel 
SUPPLEMENTAL METHODS
Generation of vascular cells from human induced pluripotent stem cells (hiPSC)
The generation of iPSCs from neonatal human dermal fibroblasts (NHDFs) was accomplished by lentiviral transduction of a polycistronic cassette harboring OCT4, SOX2, KLF4, and cMYC (pHAGE2-EF1α-STEMCCA, a gift from Dr. Gustavo
Mostoslavsky, the Boston University School of Medicine). 14 Sleeping Beauty transduction method (Amaxa, Gaithersburg, MD) as previously described. 15 The methods of vascular differentiation of hiPSCs have been reported previously. 16 Briefly, hiPSCs were maintained on mouse embryonic fibroblasts. 
Characterization of hiPSC-derived vascular cells (hiPSC-VCs)
Detailed methods for characterizing the hiPSC-VCs via flow cytometry and immunostaining have been published previously. 16 Briefly, flow cytometry analysis was performed with hiPSC-ECs that had been stained with fluorescently labeled (PE)
antibodies against CD31, CD73, CD105, and CD146 or isotypes (BD Pharmingen, San 
In vivo swine of ischemia reperfusion
Female Yorkshire farm swine (~15 kg, Manthei hog farm, Elk River, MN) were randomly assigned to one of three experimental groups: CELL (n=14), MI (n=13), and Normal (n=15). The induction of experimental myocardial ischemia-reperfusion injury has been described previously. 17, 18 Briefly, animals were anesthetized with inhaled 2% isoflurane, 
Cardiac MRI
MRIs were performed to assess cardiac function by using a 1.5 Tesla clinical scanner (Siemens Sontata, Siemens Medical Systems, Islen NJ) with a phased-array 4-channel surface coil and ECG gating [21] [22] [23] . Animals were anesthetized with 2% inhaled isoflurane and positioned in a supine position within the scanner. Cardiac function (ejection fraction and thickening fraction) was analyzed from short-axis cine images by using the Pi→ATP (k Pi→ATP ) were determined via the conventional MST approach (by using equation [8] and the results from experiment/spectra 1, 3, and 4. The rate constants of k r,tot and k ATP→Pi were determined via our novel, indirect approach (by using equations [16] and [18] and the results from experiment/spectra 2, 3, and 5.
In vivo cardiac 31 
P MRS assessments
The surgical procedure for open-chest 31 P MRS has been described previously. 21 Briefly, animals were anesthetized with 2% isoflurane and ventilated with supplemental oxygen on a respirator. Polyvinyl chloride catheters (3-mm outer diameter) were inserted into the jugular vein, ascending aorta (through the left external carotid artery), and left ventricle (through the apical dimple) for drug administration and hemodynamic monitoring; the LV catheter was introduced after the heart had been exposed via a sternotomy and suspended in a pericardial cradle. Ventilation rate, volume, and inspired oxygen content were adjusted to maintain physiological values for arterial pO 2 , pCO 2 , and pH. Aortic and LV pressures were continuously monitored throughout the study. 
hiPSC-VC engraftment rate
hiPSC-VC engraftment was evaluated by immuno-staining for GFP expression; 4 hearts were evaluated at each time point. After sacrifice, the LV was sectioned into 6 short-axis rings (~1-cm thickness) from the base to the apex as previously described, 17 and each ring was sectioned into 12 blocks as indicated by the coronary anatomy; then, every second block from every second ring was paraffin embedded and sequentially cut into The mean cross-section diameter for BrdU + cardiomyocytes were compared to that of BrdU -cardiomyocytes from the same region.
SUPPLEMENTAL RESULTS
Pulses and pulse sequences for magnetization saturation transfer (MST) experiments
The MST experiments were performed by using a BISTRO pulse sequence to ensure frequency-selective elimination of magnetization in the presence of B 1 -inhomogeneity from the surface coil. (Supplemental Figure 1A) . 24, 25 Spin magnetization was excited with frequency-selective hyperbolic secant (HS) pulses of varying power levels ( Figure   2B -C, red curves) and subsequently eliminated with de-phasing gradients. Double saturation was achieved by creating a composite pulse from two HS pulses with different excitation frequencies (Supplemental Figure 1B -C, blue curves). The magnetization response to the composite pulse is shown in Figure 3 (blue curve), where two excitation bands with distinct frequencies were observed (Supplemental Figure 1D a and b). A larger bandwidth was used for excitation frequency b to compensate for any change in the chemical shift of Pi that could result from variations of pH. ) via equation [17] (Supplemental Table 1 ). Under steady state condition, the ATP level is maintained, which means that the total ATP production rate must equal the utilization rate. The total ATP production rate is calculated by adding 
Merits of the indirect
P MRS-MST approach
Conventional approaches for measuring ATP→Pi kinetics have not been used successfully for routine in-vivo assessments of cardiac ATP metabolism. 4, 5, 30 Robitaille and colleagues used the conventional MRS-MST method to monitor the cardiac ATP turnover rate during global myocardial ischemia, when myocardial Pi increased to measurable levels, but measurements in healthy hearts or hearts with regional ischemia have been problematic. 31 Portman determined that in lamb hearts, the unidirectional ), but the author acknowledged that the experiments were limited by an extended scan time and a poor signal-to-noise ratio for quantification of Pi.
The relationship between scan time and the signal-to-noise ratio of an MR spectrum is Table 1 ). Thus, our novel indirect 31 P MRS-MST method dramatically reduces the scan time and improves the signal-to-noise ratio by eliminating the need to quantify Pi levels.
The total scan time, including the measurement of T 1 , is ~30 min, and if the T 1 s are already known (as when the same heart is re-evaluated under different workload conditions), the scan time needed for the three-spectra MST experiment is only 8 min.
These advantages are likely to be relevant for investigations of many organs and physiological systems, because even in tissues where Pi can be quantified, such as the brain and skeletal muscle, it is much less abundant, and has a much longer T 1 , than PCr or ATP. 4 We have also recently developed a T 1 nom method that enables the ATP turnover rate to be accurately quantified under partially relaxed conditions, thereby reducing the scan time of the MST experiment by up to an order of magnitude. 21 The 
Supplemental Video 4.
Representative cardiac cine imaging of a CELL heart at 4 weeks post infarction.
